Hyaluronic Acid Segment to Grow Significantly During 2021–2028
According to our latest research study on “Dermal Fillers Market Forecast to 2028 – COVID-19 Impact and Global Analysis – Product, Material, Application, and End User,” the market is projected to reach 9,421.33 million by 2028 from US$ 4,391.98 million in 2021; it is estimated to grow at a CAGR of 11.5% from 2021 to 2028. The report highlights trends prevailing in the market and the factors driving and restraining the market growth.
Dermal fillers are anti-aging products that are injected into the skin of patients to add volume. They are injected to make the sagging skin or the skin that has become wrinkled because of age look smooth and plump. They are also called injectable facial fillers, injectable cosmetic fillers, or soft tissue fillers. They are made of hyaluronic acid taken from animals or from the fat of the patient. It takes five minutes to an hour to perform dermal filler procedures. Intradermal fillers can be used in dermatological practices with minimal overhead costs. They address the issues such as facial volume loss and dynamic lines, which are the main indications of facial aging. They provide dermatological practitioners with an array of flexible treatment options for balanced and holistic results. An increase in preference for minimally invasive procedures, growth in population belonging to age group 30–65, and rise in consumer attraction toward beauty and wellness are among the main factors fueling the dermal fillers market growth. However, the high cost of surgeries hampers the market growth.
Based on material, the dermal fillers market has been segmented into calcium hydroxylapatite, hyaluronic acid, collagen, poly-l-lactic acid, polymethylmethacrylate (PMMA), fat, and other materials. The hyaluronic acid segment is likely to hold the largest share of the market in 2021, and the collagen segment is anticipated to register the highest CAGR in the market during the forecast period. FDA-approved hyaluronic acid fillers include Juvéderm products-Juvéderm XC, VOLUMA, VOLBELLA, and VOLLURE; Restylane products: Restylane, Restylane Silk, Restylane Lyft, Restylane Refyne, Restylane Defyne, Restylane Kysse, and Restylane Contour; Belotero Balance; Revanesse Versa; and the RHA collection: RHA 2, RHA 3, and RHA 4.
AbbVie Inc., Galderma, Merz Pharma, Suneva Medical, BIOXIS pharmaceuticals, HUADONG MEDICINE CO.,LTD, BIOPLUS CO., LTD., TEOXANE LABORATORIES, BIOHA LABORATORIES, and Prollenium Medical Technologies, among others, are the leading companies operating in the dermal fillers market.
Report segments dermal fillers market as follows:
The dermal fillers market is segmented on the bases of product, material, application, and end user. Based on product, the market has been segmented into biodegradable and non-biodegradable. Based on material, the dermal fillers market has been segmented into calcium hydroxylapatite, hyaluronic acid, collagen, poly-l-lactic acid, polymethylmethacrylate (PMMA), fat, and other materials. Based on application, the market has been segmented into facial line correction treatment, lip enhancement, facelift, scar treatment, and others. Based on end user, the dermal fillers market has been segmented into dermatology clinics, multispecialty hospitals, ambulatory surgical centers, and others.
By Geography
- North America
- Europe
- France
- Germany
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East & Africa (MEA)
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of South and Central America
Contact UsContact Person: Sameer JoshiPhone: +1-646-491-9876Email Id: sales@reportsweb.com
